Your session is about to expire
← Back to Search
mpMRI Monitoring for Prostate Cancer
Study Summary
This trial is testing if multiparametric magnetic resonance imaging (mpMRI) can help improve active surveillance (AS) for low and intermediate risk prostate cancer. AS uses biopsies, prostate specific antigen (PSA) blood tests, and other tools to monitor disease progression.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had treatment directly on my prostate for cancer.My prostate cancer has spread beyond the prostate.I have had radiation treatment to my pelvic area.I've had pelvic surgery that affects imaging or biopsy accuracy.I am a man and I am 18 years old or older.My prostate cancer has a Gleason score of 7 or less, with a primary pattern of 3.I cannot have a prostate biopsy due to health reasons.I cannot have an MRI due to allergies or kidney issues.My prostate cancer was confirmed by a biopsy within the last 2 years.My breast cancer is at an early stage, not very large or spread.My bleeding disorder is untreated, unstable, and my blood clotting tests are abnormal.My prostate cancer has spread beyond the prostate as shown by an mpMRI.I have severe hemorrhoids (grade 3 or above).
- Group 1: AS + mpMRI
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are involved in this experiment?
"Affirmative. Clinicaltrials.gov displays that this clinical trial, which was introduced on November 18th 2022, is currently accepting applicants. In total, 508 subjects are expected to be enrolled from one medical center."
Is this research endeavor currently enrolling participants?
"Indeed, the information from clinicaltrials.gov reports that this medical trial is actively seeking volunteers to participate. The study was first published on November 18th 2022 and has since been updated in December 1st 2022. Currently, 508 patients are being recruited at a single site for further evaluation."
Share this study with friends
Copy Link
Messenger